Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative group

This publication has 8 references indexed in Scilit:

• P3.15-003 Second Line Chemotherapy in SCLC: The West of Scotland Experience
  Journal of Thoracic Oncology, 2017
• Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell lung cancer in a randomized phase II study : Postmus PE, Splinter TAW, Palmen FMLHG, Carney DN, Festen J, Burghouts JThW et al. Department of Pulmonary Diseases, University Hospital, Oostersingel 59, 9713 EZ Groningen. Eur J Cancer 1992;28:96–100
  Lung Cancer, 1992
• Comparison of two carboplatin-containing regimens with standard chemotherapy for small cell Lung Cancer in a randomised phase II study
  European Journal Of Cancer, 1992
• Second line chemotherapy in small cell lung cancer
  Lung Cancer, 1989
• A phase II study of carboplatin and vincristine in previously treated patients with small-cell lung cancer
  Cancer Chemotherapy and Pharmacology, 1989
• The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16–213, doxorubicin and vincristine (VPAV) for small cell lung cancer
  European Journal of Cancer and Clinical Oncology, 1988
• Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy
  European Journal of Cancer and Clinical Oncology, 1987
• Alternating Drug Combinations in the Treatment of Advanced Hodgkin's Disease
  New England Journal of Medicine, 1982